Filtros : "APOPTOSE" "EERP" Removido: "2001" Limpar

Filtros



Refine with date range


  • Source: Brazilian Journal of Medical and Biological Research. Unidades: FMRP, EERP

    Subjects: APOPTOSE, QUIMIOTERAPIA, FÁRMACOS (TRATAMENTO)

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LIZARTE NETO, Fermino Sanches et al. Kaurene diterpene induces apoptosis in U87 human malignant glioblastoma cells by suppression of anti-apoptotic signals and activation of cysteine proteases. Brazilian Journal of Medical and Biological Research, v. 46, n. 1, p. 71-78, 2013Tradução . . Disponível em: https://doi.org/10.1590/1414-431X20121423. Acesso em: 06 out. 2024.
    • APA

      Lizarte Neto, F. S., Tirapelli, D. P. da C., Ambrosio, S. R., Tirapelli, C. R., Oliveira, F. M., Novais, P. C., et al. (2013). Kaurene diterpene induces apoptosis in U87 human malignant glioblastoma cells by suppression of anti-apoptotic signals and activation of cysteine proteases. Brazilian Journal of Medical and Biological Research, 46( 1), 71-78. doi:10.1590/1414-431X20121423
    • NLM

      Lizarte Neto FS, Tirapelli DP da C, Ambrosio SR, Tirapelli CR, Oliveira FM, Novais PC, Peria FM, Oliveira HF de, Carlotti Júnior CG, Tirapelli LF. Kaurene diterpene induces apoptosis in U87 human malignant glioblastoma cells by suppression of anti-apoptotic signals and activation of cysteine proteases [Internet]. Brazilian Journal of Medical and Biological Research. 2013 ; 46( 1): 71-78.[citado 2024 out. 06 ] Available from: https://doi.org/10.1590/1414-431X20121423
    • Vancouver

      Lizarte Neto FS, Tirapelli DP da C, Ambrosio SR, Tirapelli CR, Oliveira FM, Novais PC, Peria FM, Oliveira HF de, Carlotti Júnior CG, Tirapelli LF. Kaurene diterpene induces apoptosis in U87 human malignant glioblastoma cells by suppression of anti-apoptotic signals and activation of cysteine proteases [Internet]. Brazilian Journal of Medical and Biological Research. 2013 ; 46( 1): 71-78.[citado 2024 out. 06 ] Available from: https://doi.org/10.1590/1414-431X20121423
  • Source: British Journal of Pharmacology. Unidade: EERP

    Subjects: APOPTOSE, CITOCINAS, HIPERTROFIA VENTRICULAR ESQUERDA, ECOCARDIOGRAFIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ACEROS, H. et al. Moxonidine improves cardiac structure and performance in SHR through inhibition of cytokines, p38 MAPK and AKT. British Journal of Pharmacology, v. 164, n. 3, p. 946-957, 2011Tradução . . Disponível em: https://doi.org/10.1111/j.1476-5381.2011.01355.x. Acesso em: 06 out. 2024.
    • APA

      Aceros, H., Farah, G., Cobos-Puc, L., Stabile, A. M., Noiseux, N., & Mukaddam-Daher, S. (2011). Moxonidine improves cardiac structure and performance in SHR through inhibition of cytokines, p38 MAPK and AKT. British Journal of Pharmacology, 164( 3), 946-957. doi:10.1111/j.1476-5381.2011.01355.x
    • NLM

      Aceros H, Farah G, Cobos-Puc L, Stabile AM, Noiseux N, Mukaddam-Daher S. Moxonidine improves cardiac structure and performance in SHR through inhibition of cytokines, p38 MAPK and AKT [Internet]. British Journal of Pharmacology. 2011 ; 164( 3): 946-957.[citado 2024 out. 06 ] Available from: https://doi.org/10.1111/j.1476-5381.2011.01355.x
    • Vancouver

      Aceros H, Farah G, Cobos-Puc L, Stabile AM, Noiseux N, Mukaddam-Daher S. Moxonidine improves cardiac structure and performance in SHR through inhibition of cytokines, p38 MAPK and AKT [Internet]. British Journal of Pharmacology. 2011 ; 164( 3): 946-957.[citado 2024 out. 06 ] Available from: https://doi.org/10.1111/j.1476-5381.2011.01355.x
  • Source: Life Sciences. Unidade: EERP

    Subjects: INSUFICIÊNCIA CARDÍACA, ECOCARDIOGRAFIA, APOPTOSE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      STABILE, Angelita Maria et al. Functional and molecular effects of imidazoline receptor activation in heart failure. Life Sciences, v. 88, n. 11-12, p. 493-503, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.lfs.2011.01.008. Acesso em: 06 out. 2024.
    • APA

      Stabile, A. M., Aceros, H., Stockmeyer, K., Rahman, A. A. A., Noiseux, N., & Mukaddam-Daher, S. (2011). Functional and molecular effects of imidazoline receptor activation in heart failure. Life Sciences, 88( 11-12), 493-503. doi:10.1016/j.lfs.2011.01.008
    • NLM

      Stabile AM, Aceros H, Stockmeyer K, Rahman AAA, Noiseux N, Mukaddam-Daher S. Functional and molecular effects of imidazoline receptor activation in heart failure [Internet]. Life Sciences. 2011 ; 88( 11-12): 493-503.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/j.lfs.2011.01.008
    • Vancouver

      Stabile AM, Aceros H, Stockmeyer K, Rahman AAA, Noiseux N, Mukaddam-Daher S. Functional and molecular effects of imidazoline receptor activation in heart failure [Internet]. Life Sciences. 2011 ; 88( 11-12): 493-503.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/j.lfs.2011.01.008

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024